Powered by

Fennec Pharmaceuticals rises to test 4.0 February 27, 2017 17:00 EST

Feb 27, 2017 - News Bites Canadian Markets


Fennec Pharmaceuticals Inc. (TSX:FRX), Canada's 24th largest Biotechnology company by market cap, rebounded after hitting a low for the day of CAD3.84 and rose back to test the 4.0 hurdle. The stock price has soared 55.0c (15.5%) from its last trading session of February 24., compared with the S&P/TSX 60 Index which fell 2.5 points (0.3%) in the day for a relative price increase of 15.8%. The volume was 0.2 times the average daily trading volume of 42,416 shares...